Thomas Spires
Impact in
- Immunology top 10%
- Phagocytosis and Immune Regulation
-
- Occupational and environmental lung diseases
- Prostate Cancer Treatment and Research
- Pleural and Pulmonary Diseases
Papers in
-
- Prostate Cancer Treatment and Research 4
- Lung Cancer Treatments and Mutations 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Marco M. Gottardis (5 shared papers)Cheryl A. Rizzo (4 shared papers)Ricardo M. Attar (4 shared papers)J. Suso Platero (2 shared papers)Liang Schweizer (2 shared papers)Michael Quigley (3 shared papers)Mary Ellen Cvijic (4 shared papers)Qiuyan Wu (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Cancer Research (3 papers)Clinical Cancer Research (1 paper)The Prostate (1 paper)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Thomas Spires
15 papers receiving 782 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Immunology 223
- Pulmonary and Respiratory Medicine 268
- Oncology 182
- Cardiology and Cardiovascular Medicine 132
- Endocrinology, Diabetes and Metabolism 78
Countries citing papers authored by Thomas Spires
This map shows the geographic impact of Thomas Spires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Spires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Spires more than expected).
Fields of papers citing papers by Thomas Spires
This network shows the impact of papers produced by Thomas Spires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Spires. The network helps show where Thomas Spires may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Spires, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 Hit paper breakdown → | 2022 | 158 |
| 2 | 2020 | 153 | |
| 3 | 2008 | 98 | |
| 4 | 2019 | 93 | |
| 5 | 2020 | 61 | |
| 6 | 2019 | 54 | |
| 7 | 2009 | 38 | |
| 8 | 2006 | 36 | |
| 9 | 2019 | 30 | |
| 10 | 2005 | 22 | |
| 11 | 2021 | 14 | |
| 12 | 2016 | 11 | |
| 13 | 2024 | 10 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 5 |
About Thomas Spires
Thomas Spires is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism, Genetics and Immunology, having authored 15 papers that have together received 790 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Treatment and Research (4 papers), Estrogen and related hormone effects (4 papers), Phagocytosis and Immune Regulation (3 papers), Hormonal and reproductive studies (3 papers), Heart Failure Treatment and Management (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Immunology (223 citations), Pulmonary and Respiratory Medicine (268 citations), Oncology (182 citations), Cardiology and Cardiovascular Medicine (132 citations) and Endocrinology, Diabetes and Metabolism (78 citations). Thomas Spires has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Marco M. Gottardis, Cheryl A. Rizzo, Ricardo M. Attar, J. Suso Platero, Liang Schweizer, Michael Quigley, Mary Ellen Cvijic, Qiuyan Wu, Tai-An Lin and Raymond B. Birge. Their work appears in journals such as Annals of Oncology, Bioorganic & Medicinal Chemistry Letters, Cancer Research, Clinical Cancer Research and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.